Per2 participates in AKT-mediated drug resistance in A549/DDP lung adenocarcinoma cells.
about
Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer.Effect of Period 2 on the proliferation, apoptosis and migration of osteosarcoma cells, and the corresponding mechanisms.Inhibition of GLUT-1 expression and the PI3K/Akt pathway to enhance the chemosensitivity of laryngeal carcinoma cells in vitro
P2860
Per2 participates in AKT-mediated drug resistance in A549/DDP lung adenocarcinoma cells.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Per2 participates in AKT-mediated drug resistance in A549/DDP lung adenocarcinoma cells.
@en
Per2 participates in AKT-mediated drug resistance in A549/DDP lung adenocarcinoma cells.
@nl
type
label
Per2 participates in AKT-mediated drug resistance in A549/DDP lung adenocarcinoma cells.
@en
Per2 participates in AKT-mediated drug resistance in A549/DDP lung adenocarcinoma cells.
@nl
prefLabel
Per2 participates in AKT-mediated drug resistance in A549/DDP lung adenocarcinoma cells.
@en
Per2 participates in AKT-mediated drug resistance in A549/DDP lung adenocarcinoma cells.
@nl
P2093
P2860
P356
P1433
P1476
Per2 participates in AKT-mediated drug resistance in A549/DDP lung adenocarcinoma cells.
@en
P2093
Jianqing Wu
Shuangshuang Wu
Weihong Zhao
P2860
P304
P356
10.3892/OL.2016.5430
P577
2016-11-24T00:00:00Z